Abstract
Objective: To report the fetal outcome of a baby with paternal exposure to irbesartan and other antihypertensive and antidiabetic drugs. Case: The baby was conceived by in vitro fertilization with an egg obtained from a woman with untreated diabetes and hypertension and the sperm from a male with type-2 diabetes and hypertension. At the time of sperm donation, he was taking irbesartan 150 mg d-1 in addition to amlodipine, aspirin, carvedilol, glibenclamide, hydrochlorothiazide, metformin, ramipril, and triazolam. At 38 weeks gestation, a 3,090 g female baby was delivered by cesarean section due to placenta previa. At 40 months postnatal age, the baby was 18 kg with normal growth and development. Conclusion: This case suggests that paternal exposure to irbesartan as part of a combination therapy with other antihypertensive drugs and antidiabetics, does not alter sperm cells or increase the risk for fetal malformations.
| Original language | English |
|---|---|
| Pages (from-to) | 24-26 |
| Number of pages | 3 |
| Journal | Journal of Clinical Pharmacology and Pharmacoepidemiology |
| Volume | 1 |
| Issue number | 1 |
| Publication status | Published - 2010 Jun 15 |
Fingerprint
Keywords
- Angiotensin II type 1 receptor blockers
- Antihypertensive agents
- Paternal exposure
- Sartans
ASJC Scopus subject areas
- Pharmacology (medical)
- Epidemiology
- Pharmacology
Cite this
Paternal exposure to irbesartan coadministered with multiple antihypertensive and antidiabetic drugs : A case report of a baby born healthy. / Hong, Soon Cheol; Han, Jung Yeol; Choi, June Seek; Ahn, Hyun Kyong; Velázquez-Armenta, E. Yadira; Nava-Ocampo, Alejandro A.
In: Journal of Clinical Pharmacology and Pharmacoepidemiology, Vol. 1, No. 1, 15.06.2010, p. 24-26.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Paternal exposure to irbesartan coadministered with multiple antihypertensive and antidiabetic drugs
T2 - A case report of a baby born healthy
AU - Hong, Soon Cheol
AU - Han, Jung Yeol
AU - Choi, June Seek
AU - Ahn, Hyun Kyong
AU - Velázquez-Armenta, E. Yadira
AU - Nava-Ocampo, Alejandro A.
PY - 2010/6/15
Y1 - 2010/6/15
N2 - Objective: To report the fetal outcome of a baby with paternal exposure to irbesartan and other antihypertensive and antidiabetic drugs. Case: The baby was conceived by in vitro fertilization with an egg obtained from a woman with untreated diabetes and hypertension and the sperm from a male with type-2 diabetes and hypertension. At the time of sperm donation, he was taking irbesartan 150 mg d-1 in addition to amlodipine, aspirin, carvedilol, glibenclamide, hydrochlorothiazide, metformin, ramipril, and triazolam. At 38 weeks gestation, a 3,090 g female baby was delivered by cesarean section due to placenta previa. At 40 months postnatal age, the baby was 18 kg with normal growth and development. Conclusion: This case suggests that paternal exposure to irbesartan as part of a combination therapy with other antihypertensive drugs and antidiabetics, does not alter sperm cells or increase the risk for fetal malformations.
AB - Objective: To report the fetal outcome of a baby with paternal exposure to irbesartan and other antihypertensive and antidiabetic drugs. Case: The baby was conceived by in vitro fertilization with an egg obtained from a woman with untreated diabetes and hypertension and the sperm from a male with type-2 diabetes and hypertension. At the time of sperm donation, he was taking irbesartan 150 mg d-1 in addition to amlodipine, aspirin, carvedilol, glibenclamide, hydrochlorothiazide, metformin, ramipril, and triazolam. At 38 weeks gestation, a 3,090 g female baby was delivered by cesarean section due to placenta previa. At 40 months postnatal age, the baby was 18 kg with normal growth and development. Conclusion: This case suggests that paternal exposure to irbesartan as part of a combination therapy with other antihypertensive drugs and antidiabetics, does not alter sperm cells or increase the risk for fetal malformations.
KW - Angiotensin II type 1 receptor blockers
KW - Antihypertensive agents
KW - Paternal exposure
KW - Sartans
UR - http://www.scopus.com/inward/record.url?scp=77953332208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953332208&partnerID=8YFLogxK
M3 - Article
VL - 1
SP - 24
EP - 26
JO - The BMJ
JF - The BMJ
SN - 0730-6512
IS - 1
ER -